Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-10

Clinical Trial Update: Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Laxymig as a preventive treatment for migraine has completed, assessing its effects in patients with and w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Laxymig

Snippet

Sponsor: Lotus Pharmaceutical | Conditions: Migraine With Aura, Migraine Without Aura | Phase 3 | Status: COMPLETED